NYSE$EHAB
Enhabit Inc · Q4 2024 earnings
Q4 2024 earnings · · Investor relations
Briefing
Enhabit reported its fourth quarter 2023 results, showing a slight decrease in total net service revenue but strong growth in home health Medicare Advantage admissions and improved hospice metrics.
Enhabit, Inc. reported positive fourth quarter results driven by strong growth in home health Medicare Advantage admissions, continued payor innovation success, and improved quality outcomes. Despite a slight decrease in total net service revenue, the company saw significant increases in non-episodic admissions and improved hospice cost efficiency.
- Net service revenue for Q4 2023 was $260.6 million, a slight decrease from $263.2 million in Q4 2022.
- Adjusted EBITDA for Q4 2023 was $25.2 million, down from $30.3 million in Q4 2022.
- Home health non-episodic admissions grew by 34.2% year over year, contributing to a total admission growth of 3.9%.
- Hospice cost per day decreased to $76, stabilizing after three quarters at $77.
Headline financials
Revenue & EPS history
Enhabit · Revenue · Quarterly
$261M
Revenue by segment
Enhabit · $261M total across 2 segments · Q4 2024
- Home Health$210M—80.4%
- Hospice$51.1M—19.6%
Forward guidance
Enhabit is providing full-year 2024 guidance with projected net service revenue between $1,076 million and $1,102 million, Adjusted EBITDA between $98 million and $110 million, and Adjusted EPS between $0.12 and $0.43.
Tailwinds
- Projected full-year 2024 net service revenue of $1,076 million to $1,102 million.
- Anticipated full-year 2024 Adjusted EBITDA of $98 million to $110 million.
- Expected full-year 2024 Adjusted EPS of $0.12 to $0.43.
- Continued focus on payor innovation and national contracts.
- Strong performance in quality outcomes.
Headwinds
- The guidance ranges indicate potential variability in financial performance.
- Continued shift to more non-episodic admissions in home health may impact consolidated revenue.
- Uncertainties related to future impact of items outside the Company's control.
- Potential for ongoing litigation and restructuring activities.
- Market and economic conditions could affect demand for services.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 14 quarterly earnings reports · overlaid with Q4 2024
+1.9%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+8.6%
Avg return
30 days after
40%
6 / 15 earnings
Positive
+18.2%
Q1 2025
Best reaction
-6.1%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +0.1% | — | |
| Q4 2025 | +0.0% | +0.0% | +2.9% | |
| Q3 2025 | -6.1% | -2.7% | +13.6% | |
| Q2 2025 | +15.2% | +11.4% | +15.1% | |
| Q1 2025 | +18.2% | +27.7% | +31.7% | |
| Q4 2024 | +1.6% | +2.3% | +13.3% | |
| Q3 2024 | -0.4% | -5.7% | -12.0% | |
| Q2 2024 | +0.0% | -3.1% | +14.8% | |
| Q1 2024 | +0.0% | -5.4% | -13.4% | |
| Q4 2022 | +0.0% | -5.7% | -0.4% | |
| Q3 2023 | +6.1% | +6.7% | +19.3% | |
| Q2 2023 | -2.6% | -2.9% | +5.6% | |
| Q1 2023 | -4.5% | -6.0% | -2.0% | |
| Q3 2022 | -0.1% | +1.9% | +11.3% | |
| Q2 2022 | +1.7% | +5.1% | +20.6% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro